Unlike the US FDA, the CHMP doesn't recommend approval for pre-chemo prostate cancer.
ApexOnco Front Page
Recent articles
ERAS-0015 data look good, but the company is punished for a pneumonitis death.
JSKN027 will become the first ADC with this mechanism to enter human trials.
A binary Xpovio catalyst is set for March.
BeOne terminates a MUC1-targeting project.
Welireg, Padcev, and a surprise fillip for Flare.
AZD0120’s first pivotal trial will test settings as early as the second line.
Two new pivotal Chinese first-line trials have started in lung cancer.
